Showing 1451-1460 of 7316 results for "".
Pearls for Treating Skin Cancer
https://practicaldermatology.com/topics/general-topics/pearls-for-treating-skin-cancer/18446/When should you treat basal cell carcinomas with adjuvant therapies before excising? Why is the number two important to remember when treating squamous cell carcinoma? Is Merkel cell carcinoma on the rise? Gary Goldenberg, MD answers these questions and offers an update on the newest therapies and bRe-introducing Ortho Dermatologics, Tremfya Approved, Obagi Acquired
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-re-introducing-ortho-dermatologics-tremfya-approved-obagi-acquired/18458/Valeant Pharmaceuticals is changing the name of its dermatology division to Ortho Dermatologics. In an exclusive interview with DermWireTV, Executive Vice President and dermatology industry veteran William Bill Humphries discusses the change. The FDA has approved Janssen Biotech's Tremfya (guselkumaWhy Your Dermatology Practice Should Be On Instagram
https://practicaldermatology.com/topics/practice-management/dermpracticeinstagram/18473/Instagram is different from most social networks. And it's growing quickly with skyrocketing mobile technology use. It's a marketing opportunity for dermatologists, especially those interested in cosmetic procedures. Learn how to use Instagram for your practice marketing and outreach in this Ekwa.coNeuromodulators in Medical Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/neuromodulators-in-medical-dermatology/18520/Physicians are exploring the effects of botulinum toxins on several medical dermatology conditions. Erin Gilbert, MD talks to Joel Cohen, MD about her experience treating rosacea, and discusses the need for better randomized trials to explore treatment options.Rhofade Approved, Sun Leaves Acne Behind, Radiesse Turns 10
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-rhofade-approved-sun-leaves-acne-behind-radiesse-turns-10/18552/The FDA has approved Allergan's Rhofade (Oxymetazoline 1%) cream for the topical treatment of persistent facial erythema associated with rosacea in adults. New research from Olay in collaboration with personal genetics company 23andMe shows that taking care of the skin may be the key to looking upBuilding a Successful Practice
https://practicaldermatology.com/topics/practice-management/building-a-successful-practice/18563/From branding tips to employee management and engagement strategies, this episode of Derm Insider focuses on how to run a successful and profitable private practice. Host Neal Bhatia, MD asks Sarah Jackson, MD and Deirdre Hooper, MD to share pearls that have led to their success at Audubon DermatolConquer Burnout
https://practicaldermatology.com/topics/practice-management/conquer-burnout/18732/Recognizing the signs of burnout is the first step to conquering this epidemic among physicians. Leading dermatologists Brian Berman, MD, PhD and Neil Sadick, MD talk to host Neal Bhatia, MD about the latest research into physician burnout and the probable causes, from an increase in legislative issLasers in Acne: Expanding the Options
https://practicaldermatology.com/topics/general-topics/lasers-in-acne-expanding-the-options/18745/By Abigail Waldman, MD and Seemal R. Desai, MDThe Nd-YAG (1064nm) laser can be used for acne—including cystic acne—and acne scarring. Dr. Waldman discusses the AAD's first-ever hands-on laser session and the role of the Nd-YAG laser in patient care.Risk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORMeaningful Approaches to Vitiligo
https://practicaldermatology.com/topics/general-topics/meaningful-approaches-to-vitiligo/18599/As science continues to uncover more about vitiligo and its treatment, dermatologists have more options than ever. But there's still work to be done. In this edition of Ask an Expert, host Adam Friedman, MD talks to John E. Harris, MD, PhD, Director of the Vitiligo Clinic and Research Center at Univ